Home/Filings/4/0001144204-18-053877
4//SEC Filing

POSNER BRIAN M 4

Accession 0001144204-18-053877

CIK 0001279704other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 7:49 PM ET

Size

6.1 KB

Accession

0001144204-18-053877

Insider Transaction Report

Form 4
Period: 2018-10-12
POSNER BRIAN M
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2018-10-12+54,00054,000 total
    Exercise: $2.61Exp: 2028-10-12Common Stock (54,000 underlying)
Footnotes (1)
  • [F1]This option grant was divided into a definitive grant of 25,559 shares, which vest as to all shares on the first anniversary of the grant date, and a contingent grant of 28,441 shares, which are subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the contingent grant shall vest over a period of three years from the grant date, vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.

Issuer

Cellectar Biosciences, Inc.

CIK 0001279704

Entity typeother

Related Parties

1
  • filerCIK 0001287711

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:49 PM ET
Size
6.1 KB